Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Unity Biotechnology, Inc. (UBX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 581 shares
@ $2.94, valued at
$1.7k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,212 shares
@ $3.39, valued at
$4.1k
|
|
| 05/12/2023 |
4
| Sullivan Lynne Marie (See Remarks) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.77, valued at
$110.8k
Disposed/sold 24,000 options to buy
@ $99.6, valued at
$2.4M
Granted 24,000 options to buy
@ $2.77, valued at
$66.5k
Disposed/sold 12,333 options to buy
@ $41.8, valued at
$515.5k
Granted 12,333 options to buy
@ $2.77, valued at
$34.2k
Disposed/sold 20,000 options to buy
@ $10.6, valued at
$212k
Granted 20,000 options to buy
@ $2.77, valued at
$55.4k
|
|
| 05/12/2023 |
4
| Nguyen Alexander Hieu (See Remarks) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.77, valued at
$110.8k
Disposed/sold 2,083 options to buy
@ $41.8, valued at
$87.1k
Granted 2,083 options to buy
@ $2.77, valued at
$5.8k
Disposed/sold 18,332 options to buy
@ $10.6, valued at
$194.3k
Granted 18,332 options to buy
@ $2.77, valued at
$50.8k
|
|
| 05/12/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 135,000 options to buy
@ $2.77, valued at
$374k
Disposed/sold 24,999 options to buy
@ $29.4, valued at
$735k
Granted 24,999 options to buy
@ $2.77, valued at
$69.2k
Disposed/sold 15,000 options to buy
@ $59.75, valued at
$896.3k
Granted 15,000 options to buy
@ $2.77, valued at
$41.6k
Disposed/sold 29,000 options to buy
@ $41.8, valued at
$1.2M
Granted 29,000 options to buy
@ $2.77, valued at
$80.3k
Disposed/sold 56,666 options to buy
@ $10.6, valued at
$600.7k
Granted 56,666 options to buy
@ $2.77, valued at
$157k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,020 shares
@ $2.15, valued at
$2.2k
|
|
| 04/03/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,959 shares
@ $1.7, valued at
$3.3k
|
|
| 04/03/2023 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 420 shares
@ $1.7, valued at
$714 |
|
| 03/15/2023 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,005 shares
@ $4, valued at
$4k
|
|
| 03/15/2023 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 1,210 shares
@ $4, valued at
$4.8k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Sullivan Lynne Marie (CFO & Head of Corp. Dev.) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Acquired 925 shares
@ $6.89, valued at
$6.4k
Granted 80,000 options to buy
@ $2.38, valued at
$190.4k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 13,706 shares
@ $0.48, valued at
$6.6k
|
|
| 09/15/2022 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 10,923 shares
@ $0.48, valued at
$5.2k
|
|
| 08/02/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 10,446 shares
@ $0.67, valued at
$7k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Ghosh Anirvan (CEO) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Sold 12,149 shares
@ $0.59, valued at
$7.2k
|
|
| 06/27/2022 |
4
| O'Neill Gilmore Neil (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.59, valued at
$14.8k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Roberts Margo R (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.59, valued at
$14.8k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|